Loading clinical trials...
Loading clinical trials...
A Phase 1/2,Open-Label Study to Evaluate the Safety and Efficacy of the International Brain Research Foundation (IBRF) Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Patients With Severe Disorders of Consciousness
Conditions
Interventions
Polypharmacy using FDA-approved products
Median Nerve Stimulation (MNS)
+2 more
Locations
1
United States
International Brain Research Foundation
Edison, New Jersey, United States
Start Date
March 1, 2016
Primary Completion Date
March 1, 2017
Completion Date
April 1, 2017
Last Updated
September 2, 2016
NCT04521881
NCT07455136
NCT06725108
NCT06734026
NCT07357090
NCT06819592
Lead Sponsor
International Brain Research Foundation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions